Howe & Rusling’s Cymabay Therapeutics CBAY Stock Holding History

Howe & Rusling’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-200	Closed	-$1K	–	1224
2022 Q2	$1K	Buy	+200	New	+$478	﹤0.01%	1028
2019 Q2	–	Sell	-50	Closed	-$1K	–	893
2019 Q1	$1K	Hold	50	–	–	﹤0.01%	786
2018 Q4	$0	Hold	50	–	–	﹤0.01%	917
2018 Q3	$1K	Hold	50	–	–	﹤0.01%	829
2018 Q2	$1K	Buy	+50	New	+$626	﹤0.01%	791

Other funds holding CBAY

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Altium Capital Management New York $42M AUM